OBJECTIVES: Tricuspid valve reoperation (TVR) following left-sided valve surgery (LSVS) is a high-risk procedure. This study was conducted to analyse the mid-term results and risks of isolated TVR following LSVS.
INTRODUCTION
Functional tricuspid regurgitation (TR) was originally considered secondary to the left-sided valve disease (LSVD) in many patients. Earlier theories suggested that after correcting the LSVD, the pulmonary artery pressure decreased and the functional TR gradually improved until it disappeared. Thus, repair of the tricuspid valve, termed 'the forgotten valve', did not receive the necessary attention during surgical treatment of the LSVD. However, more studies [1, 2] have shown that most of the functional TR does not improve with the correction of the LSVD. In contrast, the TR continues to develop until it is eventually severe enough to cause right heart failure. Surgical treatment of tricuspid valve lesions following left-sided valve surgery (LSVS) is a difficult clinical task. This study was conducted to evaluate the mid-term outcomes of isolated tricuspid valve reoperation (TVR) following LSVS and identify the predictors of adverse outcomes.
MATERIALS AND METHODS

Study population
From May 2007 to December 2016, a total of 131 patients underwent TVR in Shanghai Chest Hospital, China. Of these 131 patients, 91 patients who underwent isolated TVR following LSVS were enrolled in this study. The inclusion criteria were previous LSVS with recurrent symptoms of right heart failure and severe TR on echocardiographic examination (moderate cases were excluded). The exclusion criterion was the presence of other heart lesions (such as autologous or artificial valve dysfunction) that were treated according to the established guidelines during the same surgery. The Ethics Research Board of Shanghai Chest Hospital approved this retrospective study.
Surgery
Cardiopulmonary bypass was performed according to the chosen surgery, such as the approach through redo sternotomy or †The first two authors contributed equally to this work. thoracotomy, beating-heart surgery or arrested heart surgery. The unilateral femoral artery was prepared before performing the median incision. Traditional aortic cannulation was performed after smooth division of the aortic adhesions. Femoral artery cannulation was chosen for arterial perfusion if a severe complication occurred. Femoral artery cannulation was also chosen for procedures involving a right fourth intercostal incision. Balloon venous drainage tubes were inserted after placement of a purse-string suture on the right atrium. Tricuspid valve surgery was performed under a normal temperature with a beating heart during the right thoracotomy procedure. Recently, we performed a right minithoracotomy tricuspid valve surgery [3] , in which the jugular vein and the femoral vein were cannulated for venous drainage with vacuum assistance. The superior vena cava and the inferior vena cava did not need to be snared.
With the development of surgical techniques and medical treatments during the 10-year study period, the patient cohort was treated by 10 surgeons. The incision, the repair or replacement and the type and size of the tricuspid valve were entirely dependent upon the personal preference of the surgeon. We initially chose valve replacement because of a concern regarding the need for a third heart surgery due to valve repair failure. Over time, we accumulated experience and satisfactory results and therefore continue to use this technique. We had also begun to perform annuloplasty procedures during the study period. In recent years, the majority of patients undergoing TVR in our centre underwent valve replacement with a 29# bioprosthetic valve. We believe that more repair surgeries will be performed in the future.
Statistical analysis
Frequency and percentage were used to describe the categorical variables, and the Fisher's exact test was used to test the difference in the distribution of categorical variables between groups (eventful recovery group versus uneventful recovery group). The eventful recovery group included the patients whose postoperative intensive care unit (ICU) stay was <72 h. The uneventful recovery group included the patients whose postoperative ICU stay was > _72 h or who died in the hospital. Mean and standard deviation were used to describe the continuous variables, and the t-test for 2 independent samples was used to test the differences in the continuous variables between groups. Multiple logistic regression was used to explore the relationship between risk factors and ICU time. The stepwise regression method was applied, and the significance level for both entry and maintenance of the variables (categorical or continuous) in the model was set at 0.1. A prolonged ICU stay was used as an outcome variable. If the ICU stay was <72 h, the variable value was 0; if the ICU stay was > _72 h or death occurred, the variable value was 1. For stepwise regression, the v 2 statistic for each effect was computed and the largest of these statistics examined. If it was significant at the entry level, the corresponding effect was added to the model. Effects were entered into and removed from the model in such a way that each forward selection step could be followed by one or more backward elimination steps. The stepwise selection process was terminated if no further effect could be added to the model or if the current model was identical to a previously visited model. Patient follow-up was conducted through telephone and mail. The surviving patients were asked to provide a recent (< _6 months) echocardiogram. Data were extracted from the hospital charts and a computerized database. The Kaplan-Meier method was used to estimate the survival time, and the stratified log-rank test was used to compare the difference in the survival time between the valve types.
All P-values are 2 sided, and a P-value of <0.05 was considered statistically significant. Statistical analysis was performed with SAS 9.4 software (SAS Institute Inc., Cary, NC, USA).
RESULTS
Early results
The baseline clinical and echocardiographic characteristics of the study population are summarized in Table 1 . The patients comprised 23 men and 68 women with a mean age of 57.5 ± 8.0 years (range 33-75 years). Most patients (93.4%) had New York Heart Association (NYHA) Class III or IV heart failure. The mean time between the development of the previous LSVS and the performance of the secondary surgery for severe TR was 14.2 ± 6.20 years (range 2-16 years). We only observed 75 (81.6%) cases of rheumatic disease and 1 (1.1%) case of degenerative aortic regurgitation, while information regarding the other patients was lost.
The in-hospital mortality rate was 2.2% (2 of 91 patients). Surgery was performed through a median incision in 14 (15.4%) patients and through a right thoracotomy in 77 (84.6%) patients. In 5 patients, tricuspid valve lesions were complicated by rheumatic stenosis, whereas the other patients exhibited isolated functional regurgitation. One patient underwent tricuspid valve repair [annuloplasty with an MC3 Tricuspid Annuloplasty Ring (Edwards Lifesciences, Irvine, CA, USA)], whereas the others underwent valve replacement using a mechanical valve in 16 (17.6%) patients and a tissue valve in 74 (81.3%) patients. Two surgeries involved the use of an aortic clamp. The mean cardiopulmonary bypass time was 71.3 ± 25.9 min (range 42-167 min), whereas the mean ICU time was 78.3 ± 86.4 h (range 17-330 h). Postoperative morbidities included 4 cases of haemofiltration, 3 cases of endotracheal reintubation, 1 readmission to the ICU, 7 re-explorations for bleeding, 2 cases of mild perivalvular leakage and 2 pacemaker insertions for third-degree atrioventricular block.
Late results
Five (5.6%) patients were lost to follow-up. Eight (9.0%) deaths occurred at a mean follow-up period of 9.21 ± 18.8 months (range 1-108 months), including 5 cardiac deaths. Six patients developed ascites/hydrothorax, 15 developed oedema of the lower limbs and 40 required oral diuretics at different doses. The NYHA class improved significantly in survivors; the postoperative NYHA class in the majority of patients (70 of 77, 90.9%) was I/II compared with a preoperative class of III/IV in 93.4% of patients.
Factors affecting intensive care unit duration
Because of the fairly low in-hospital mortality rate (2.2%), we divided the patients into 2 groups to identify the additional risk factors: the uneventful recovery group (ICU duration of <72 h) and the eventful recovery group (ICU duration of > _72 h or death). The 2 factors with a significant difference between the 2 groups were a previous aortic and mitral valve replacement (P = 0.0112) and the left ventricular end-systolic diameter (LVESD) (P = 0.0239) ( Table 2 ). Predictors of a longer ICU duration in the multivariable analysis were previous aortic and mitral valve replacement [odds ratio (OR) 0.161, P = 0.0015], preoperative central venous pressure (CVP) (OR 1.202, P = 0.0353), pulmonary artery pressure (OR 1.075, P = 0.0134) and LVESD (OR 1.13, P = 0.0155) ( Table 3 ). The preoperative CVP was defined as the CVP measured after induction of general anaesthesia and before the surgical incision.
Survival
The Kaplan-Meier curve of cumulative survival rates is shown in Fig. 1 . The Kaplan-Meier survival rates at 1 year and 5 years were 97.7% and 90.0%, respectively. Because only 1 patient underwent tricuspid valve repair, we compared the survival of patients who underwent valve replacement with a different valve. There was no difference in survival between replacement with a mechanical valve and bioprosthetic valve (P = 0.9307) (Fig. 2) .
DISCUSSION
Although the mortality rate associated with TVR has been high (8.3-23.8%) in many studies [4] [5] [6] [7] , it has shown a decreasing trend in recent years. For example, Jeong et al. [8] reported a low mortality rate of only 1.9% among inpatients undergoing TVR. Park et al. [9] reported no hospital death in a series of 51 patients. Their results might have been affected by the young onset age, appropriate myocardial protection and adequate perioperative monitoring. In this study, the in-hospital mortality rate was only 2.2% (n = 2), and the cause of death in both patients was severe right heart failure with low cardiac output.
The 2 main reasons for the higher mortality in association with TVR following LSVS may be the following. First, TR progresses slowly after the left heart valve surgery. Even when severe TR occurs, patients can still tolerate the TR for a long period in its early stage. The clinical symptoms of the right heart dysfunction may improve after medical treatment; thus, patients still have no/low willingness to undergo a second surgery. These patients may develop recurrent right heart failure including intractable oedema and pigmentation of the lower limbs, ascites, liver and kidney dysfunction and pancytopenia, which finally respond poorly to drug treatments; at this stage, the right heart function may already be in an irreversible state. In this series, the patients had undergone surgery at a mean of 14 years previously; thus, the symptoms of the right ventricular dysfunction were obvious before the operation. Up to 93.4% (n = 85) of the patients in this study had NYHA Class III or IV heart failure. Second, many studies have shown that the most common cause of death in patients who had undergone TVR following LSVS is the right-sided heart failure. The poor prognosis of these patients is mainly due to the lack of effective preoperative evaluation indexes for assessing the right heart function and the lack of effective treatment options for the right-sided heart failure. Although many tools have been used to assess the right heart function [10] , no widely recognized objective indicator for determining the right ventricular function has been established. Comparison of the right heart function parameters (laboratory findings, clinical signs and medical history) between the 2 groups in this study showed a significant difference in only 2 parameters (LVESD and previous valve surgery). Therefore, we speculate that left ventricular enlargement following the left-sided heart dysfunction may have been a cause of the poor prognosis in these patients. Multivariable regression analysis revealed that previous mitral and aortic valve replacement, preoperative CVP, pulmonary artery pressure and LVESD were high-risk factors for a prolonged postoperative ICU stay.
In terms of surgical techniques, patients who undergo TVR following LSVS are more likely to have an obviously enlarged right atrium and right ventricle than are patients who undergo a second heart surgery for the treatment of other aetiologies. The heart is thus tightly attached to the sternum with dense tissue adhesions in patients who undergo TVR following LSVS. As a result, the cardiac tissues can be easily injured during sternotomy with a swing saw and separation of adhesion tissues. Even if the heart tissue is not seriously damaged, many local ruptures of the right atrium and the right ventricle may occur, increasing intraoperative bleeding and prolonging the operative time. The oozing blood at the dissociation site also increases the postoperative drainage. Therefore, TVR via a median sternotomy is no longer performed in our centre. In recent years, minimally invasive TVR through a right thoracotomy has been carried out in our centre. The jugular vein and the femoral vein are chosen for vacuum-assisted venous drainage. The superior and inferior vena cavae are not snared, which can further reduce adhesions division and bleeding. In 4 of our patients, the perivalvular leakage site of the left-sided artificial valve was successfully closed with the interventional treatment followed by TVR via a right anterolateral incision, and the result was satisfactory. As a relatively simple procedure, it can provide adequate myocardial protection, avoid thirddegree atrioventricular block and achieve rapid postoperative recovery. In our series, 77 patients underwent TVR via a right anterolateral incision, among whom only 1 (1.30%) died. In this study, 5 (5.9%) patients underwent De Vega's tricuspid annuloplasty during the first LSVS. During the second procedure, detachment of the plasty suture or dislocation of the pledgetted mattresses at both ends was visible. The remaining patients had mild TR or even no TR, which was not managed during the first surgery. The limited data of the initial aetiology in the left-sided valves also give an indication that tricuspid valve disease after rheumatic LSVD is more prevalent. [11] Therefore, for patients undergoing rheumatic LSVS, concurrent tricuspid valve surgery (preferably tricuspid valve annuloplasty) should be actively performed according to the established guidelines to reduce the occurrence of severe TR in later stages and TVR.
In addition, patients who have undergone LSVS should attend regular follow-up visits. For any patient with symptoms of the right heart dysfunction, echocardiographic follow-up is recommended to evaluate the TR severity and structure and function of the right heart. According to the European Society of Cardiology (ESC)/ European Association for Cardio-Thoracic Surgery (EACTS) guidelines on the management of valvular heart disease (version 2012) [12] and the American College of Cardiology (ACC)/American Heart Association (AMA) guidelines (version 2014) [13] , timely and reasonable TVR can prevent the occurrence of severe right ventricular dysfunction or irreversible right heart failure and effectively reduce the perioperative risks. This may also explain the low mortality rate in our series. Age may be another reason for a better result. Our patients were younger (57.5 ± 8.0 years) than those in the study by Buzzatti et al. [14] (61.7 ± 10.7 years), who reported 30-day mortality to be 8.2% in the isolated TVR group.
CONCLUSION
In conclusion, isolated TVR is a safe and effective surgery for tricuspid valve lesions following LSVS, and right thoracotomy may be a reasonable choice. Previous mitral and aortic valve replacement, preoperative CVP, pulmonary artery pressure and LVESD were high-risk factors for a prolonged postoperative ICU stay. The valve type has no significant effect on the survival of patients who have undergone valve replacement.
